Results 11 to 20 of about 901,712 (292)
What is the status of immunotherapy in thyroid neoplasms? [PDF]
Frontiers in Endocrinology, 2022 Immunotherapy has changed the treatment of patients with advanced cancer, with different phase III trials showing durable responses across different histologies.
Alejandro Garcia-Alvarez +2 more
exaly +4 more sources
Overview of the 2022 WHO Classification of Thyroid Neoplasms
Endocrine Pathology, 2022 This review summarizes the changes in the 5th edition of the WHO Classification of Endocrine and Neuroendocrine Tumors that relate to the thyroid gland.
Zubair W Baloch +2 more
exaly +3 more sources
Pathology and new insights in thyroid neoplasms in the 2022 WHO classification [PDF]
Curr Opin Oncol, 2023 Purpose of review The assessment of thyroid nodules is a common clinical problem, linked to the high incidence of thyroid nodules in the population and the low incidence of aggressive thyroid carcinoma.
L. Lebrun, I. Salmon
semanticscholar +2 more sources
Immunohistochemistry in the pathologic diagnosis and management of thyroid neoplasms [PDF]
Front Endocrinol (Lausanne), 2023 The use of immunohistochemistry cannot be underestimated in the everyday practice of thyroid pathology. It has evolved over the years beyond the traditional confirmation of thyroid origin to molecular profiling and the prediction of clinical behavior. In
A. Crescenzi, Zubair Baloch
semanticscholar +2 more sources
European Radiology, 2022 To investigate the ability of the currently used ultrasound-based malignancy risk stratification systems for thyroid neoplasms (ATA, AACE/ACE/AME, K-TIRADS, EU-TIRADS, ACR-TIRADS and C-TIRADS) in distinguishing follicular thyroid carcinoma (FTC) from ...
Shuiqing Lai +2 more
exaly +2 more sources
Genetics, Diagnosis, and Management of Hürthle Cell Thyroid Neoplasms [PDF]
Front Endocrinol (Lausanne), 2021 Hürthle cell lesions have been a diagnostic conundrum in pathology since they were first recognized over a century ago. Controversy as to the name of the cell, the origin of the cell, and even which cells in particular may be designated as such still ...
David G. McFadden, P. Sadow
semanticscholar +2 more sources
Aggressive Types of Malignant Thyroid Neoplasms [PDF]
J Clin MedDifferentiated thyroid cancer (DTC) includes many subtypes, which demonstrate favorable to aggressive behavior. During the past decades, efforts have been made to describe aggressive thyroid cancers.
M. Boudina +3 more
semanticscholar +2 more sources
JAMA Otolaryngol Head Neck Surg, 2021 Importance Increasing detection of early-stage papillary thyroid neoplasms without improvements in mortality has prompted development of strategies to prevent or mitigate overtreatment.
L. Caulley +33 more
semanticscholar +2 more sources
Updates in the Pathologic Classification of Thyroid Neoplasms: A Review of the World Health Organization Classification. [PDF]
Endocrinol Metab (Seoul), 2020 Advances in medical sciences and evidence-based medicine have led to momentous changes in classification and management of thyroid neoplasms. Much progress has been made toward avoiding overdiagnosis and overtreatment of thyroid cancers.
Yanhua Bai, K. Kakudo, C. Jung
semanticscholar +2 more sources
Deep learning prediction of BRAF-RAS gene expression signature identifies noninvasive follicular thyroid neoplasms with papillary-like nuclear features [PDF]
Mod Pathol, 2020 Noninvasive follicular thyroid neoplasms with papillary-like nuclear features (NIFTP) are follicular-patterned thyroid neoplasms defined by nuclear atypia and indolent behavior. They harbor RAS mutations, rather than BRAFV600E mutations as is observed in
J. Dolezal +9 more
semanticscholar +2 more sources